171 related articles for article (PubMed ID: 36617632)
1. FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity.
Santo EE; Ribel-Madsen R; Stroeken PJ; de Boer VCJ; Hansen NS; Commandeur M; Vaag AA; Versteeg R; Paik J; Westerhout EM
Aging Cell; 2023 Mar; 22(3):e13763. PubMed ID: 36617632
[TBL] [Abstract][Full Text] [Related]
2. The FOXO3A rs2802292 G-allele associates with improved peripheral and hepatic insulin sensitivity and increased skeletal muscle-FOXO3A mRNA expression in twins.
Banasik K; Ribel-Madsen R; Gjesing AP; Wegner L; Andersson A; Poulsen P; Borglykke A; Witte DR; Pedersen O; Hansen T; Vaag A
J Clin Endocrinol Metab; 2011 Jan; 96(1):E119-24. PubMed ID: 20881262
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation and human longevity.
Soerensen M
Dan Med J; 2012 May; 59(5):B4454. PubMed ID: 22549493
[TBL] [Abstract][Full Text] [Related]
4. Association between genetic variations in the insulin/insulin-like growth factor (Igf-1) signaling pathway and longevity: a systematic review and meta-analysis.
Di Bona D; Accardi G; Virruso C; Candore G; Caruso C
Curr Vasc Pharmacol; 2014; 12(5):674-81. PubMed ID: 24350933
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in insulin/IGF-1 signaling pathways and longevity.
Ziv E; Hu D
Ageing Res Rev; 2011 Apr; 10(2):201-4. PubMed ID: 20868776
[TBL] [Abstract][Full Text] [Related]
6. Association of FOXO3A variation with human longevity confirmed in German centenarians.
Flachsbart F; Caliebe A; Kleindorp R; Blanché H; von Eller-Eberstein H; Nikolaus S; Schreiber S; Nebel A
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2700-5. PubMed ID: 19196970
[TBL] [Abstract][Full Text] [Related]
7. Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data.
Soerensen M; Dato S; Christensen K; McGue M; Stevnsner T; Bohr VA; Christiansen L
Aging Cell; 2010 Dec; 9(6):1010-7. PubMed ID: 20849522
[TBL] [Abstract][Full Text] [Related]
8. Adjustment for smoking does not alter the FOXO3A association with longevity.
Däumer C; Flachsbart F; Caliebe A; Schreiber S; Nebel A; Krawczak M
Age (Dordr); 2014 Apr; 36(2):911-21. PubMed ID: 24014251
[TBL] [Abstract][Full Text] [Related]
9. Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations.
Li Y; Wang WJ; Cao H; Lu J; Wu C; Hu FY; Guo J; Zhao L; Yang F; Zhang YX; Li W; Zheng GY; Cui H; Chen X; Zhu Z; He H; Dong B; Mo X; Zeng Y; Tian XL
Hum Mol Genet; 2009 Dec; 18(24):4897-904. PubMed ID: 19793722
[TBL] [Abstract][Full Text] [Related]
10. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity.
Pawlikowska L; Hu D; Huntsman S; Sung A; Chu C; Chen J; Joyner AH; Schork NJ; Hsueh WC; Reiner AP; Psaty BM; Atzmon G; Barzilai N; Cummings SR; Browner WS; Kwok PY; Ziv E;
Aging Cell; 2009 Aug; 8(4):460-72. PubMed ID: 19489743
[TBL] [Abstract][Full Text] [Related]
11. A novel AMPK-dependent FoxO3A-SIRT3 intramitochondrial complex sensing glucose levels.
Peserico A; Chiacchiera F; Grossi V; Matrone A; Latorre D; Simonatto M; Fusella A; Ryall JG; Finley LW; Haigis MC; Villani G; Puri PL; Sartorelli V; Simone C
Cell Mol Life Sci; 2013 Jun; 70(11):2015-29. PubMed ID: 23283301
[TBL] [Abstract][Full Text] [Related]
12. Birth cohort differences in the prevalence of longevity-associated variants in APOE and FOXO3A in Danish long-lived individuals.
Nygaard M; Lindahl-Jacobsen R; Soerensen M; Mengel-From J; Andersen-Ranberg K; Jeune B; Vaupel JW; Tan Q; Christiansen L; Christensen K
Exp Gerontol; 2014 Sep; 57():41-6. PubMed ID: 24809632
[TBL] [Abstract][Full Text] [Related]
13. Genetic investigation of FOXO3A requires special attention due to sequence homology with FOXO3B.
Flachsbart F; Möller M; Däumer C; Gentschew L; Kleindorp R; Krawczak M; Caliebe A; Schreiber S; Nebel A
Eur J Hum Genet; 2013 Feb; 21(2):240-2. PubMed ID: 22588664
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cAMP/Epac/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle.
Baviera AM; Zanon NM; Navegantes LC; Kettelhut IC
Mol Cell Endocrinol; 2010 Feb; 315(1-2):104-12. PubMed ID: 19804812
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the rs2802292 SNP identifies FOXO3A as a modifier locus predicting cancer risk in patients with PJS and PHTS hamartomatous polyposis syndromes.
Forte G; Grossi V; Celestini V; Lucisano G; Scardapane M; Varvara D; Patruno M; Bagnulo R; Loconte D; Giunti L; Petracca A; Giglio S; Genuardi M; Pellegrini F; Resta N; Simone C
BMC Cancer; 2014 Sep; 14():661. PubMed ID: 25208626
[TBL] [Abstract][Full Text] [Related]
16. FOXO3a: a novel player in thyroid carcinogenesis?
Karger S; Weidinger C; Krause K; Sheu SY; Aigner T; Gimm O; Schmid KW; Dralle H; Fuhrer D
Endocr Relat Cancer; 2009 Mar; 16(1):189-99. PubMed ID: 18845647
[TBL] [Abstract][Full Text] [Related]
17. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
18. Activated phosphatidylinositol 3-kinase/Akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup O-3a signaling.
Zhang Z; Zhang T; Zhou Y; Wei X; Zhu J; Zhang J; Wang C
Cell Physiol Biochem; 2015; 35(4):1643-53. PubMed ID: 25824462
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of FOXO3a by PI3K/Akt pathway in HK-2 renal proximal tubular epithelial cells exposed to cadmium.
Fujiki K; Inamura H; Matsuoka M
Arch Toxicol; 2013 Dec; 87(12):2119-27. PubMed ID: 23673518
[TBL] [Abstract][Full Text] [Related]
20. FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma.
Santo EE; Stroeken P; Sluis PV; Koster J; Versteeg R; Westerhout EM
Cancer Res; 2013 Apr; 73(7):2189-98. PubMed ID: 23378341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
